Matthew L. Trerotola - Feb 25, 2022 Form 4 Insider Report for Colfax CORP (ENOV)

Role
President & CEO, Director
Signature
/s/ Bradley Tandy, Attorney-in-Fact
Stock symbol
ENOV
Transactions as of
Feb 25, 2022
Transactions value $
-$4,018,774
Form type
4
Date filed
3/1/2022, 06:01 PM
Previous filing
Feb 25, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $.001 Award $0 +185K +54.51% $0.00 525K Feb 25, 2022 Direct F1
transaction ENOV Common stock, par value $.001 Sale -$270K -6.53K -1.25% $41.27 518K Feb 28, 2022 Direct F2
transaction ENOV Common stock, par value $.001 Sale -$2.31M -57.5K -11.1% $40.11 461K Feb 28, 2022 Direct F2, F3
transaction ENOV Common stock, par value $.001 Sale -$1.44M -34.9K -7.59% $41.18 426K Feb 28, 2022 Direct F2, F4
transaction ENOV Common stock, par value $.001 Sale -$4.17K -100 -0.02% $41.73 426K Feb 28, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.
F3 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.68 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.